Stocks · US
BIIB
XNAS
Biogen Inc. Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E39.58x
P/B1.75x
P/S3.29x
EPS$5.65
ROE4.43%
ROA2.60%
Dividend yield0.00%
EV/EBITDA17.32x
Debt/Equity0.43
Free cash flow$2.7B
Returns and 52-week range
1W-1.84%
1M+0.93%
3M+11.24%
6M+26.92%
1Y+39.41%
YTD+25.35%
52W high$230.49
52W low$138.00
From 52W high-3.30%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| BeOne Medicines Ltd. American Depositary Shares | $40.9B | 62.39 | 7.91 | +1.26% |
| DexCom, Inc. | $32.8B | 32.80 | 12.51 | -5.13% |
| Idexx Laboratories Inc | $41.5B | 36.43 | 25.75 | -3.73% |
| 센틴 | $31.8B | — | 1.41 | -3.62% |
| Waters Corp | $43.2B | 260.27 | 2.85 | +6.61% |
| 레즈메드 | $31.3B | 20.58 | 4.76 | -3.35% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.